Late response to low-dose imatinib in patients with chronic phase chronic myeloid leukemia-Reference-Cited by-同舟云学术

Late response to low-dose imatinib in patients with chronic phase chronic myeloid leukemia

Published:2012-08-15 Issue:3 Volume:96 Page:357-363
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Takami Akiyoshi,Ohtake Shigeki,Morishita Eriko,Terasaki Yasushi,Fukushima Toshihiro,Kurokawa Toshiro,Sugimori Naomi,Matano Sadaya,Ohata Kinya,Saito Chizuru,Yamaguchi Masaki,Hosokawa Kohei,Yamazaki Hirohito,Kondo Yukio,Nakao Shinji

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-012-1155-1.pdf

Reference41 articles.

1. Deininger MWN, O’Brien SG, Ford JM, Druker BJ. Practical management of patients with chronic myeloid leukemia receiving imatinib. J Clin Oncol. 2003;21(8):1637–47.

2. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med. 2001;344(14):1031–7.

3. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med. 1996;2(5):561–6.

4. Deininger MWN, Goldman JM, Lydon N, Melo JV. The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of bcr-abl–positive cells. Blood. 1997;90(9):3691–8.

5. O’Brien SG, Guilhot F, Goldman JM, Hochhaus A, Hughes TP, Radich JP, et al. International randomized study of interferon versus STI571 (IRIS) 7-year follow-up: sustained survival, low rate of transformation and increased rate of major molecular response (MMR) in patients (pts) with newly diagnosed chronic myeloid leukemia in chronic phase (CMLCP) treated with imatinib (IM). ASH Annual Meeting Abstracts 2008;112(11):186.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Visible/solar-light-driven thiyl-radical-triggered synthesis of multi-substituted pyridines;Organic & Biomolecular Chemistry;2023

2. Visible-Light-Accelerated Pd-Catalyzed Cascade Addition/Cyclization of Arylboronic Acids to γ- and β-Ketodinitriles for the Construction of 3-Cyanopyridines and 3-Cyanopyrrole Analogues;The Journal of Organic Chemistry;2020-09-10